Developer docs
API playgroundTry for free, no card

Search company profiles

Richard Wolf

Full company profile

uuid0007i23

Namestring
Richard Wolf
Legal namestring
Richard Wolf GmbH
Company typeenum
Private
Founded yearint
1906
Descriptiontext

Richard Wolf GmbH is a privately held German medical technology company headquartered in Knittlingen, Germany, specializing in endoscopic instruments and complete system solutions for minimally invasive surgery. Founded in 1906 as a family business and formally incorporated as Richard Wolf GmbH in 1947, the company has been wholly owned since 1969 by the non-profit Richard und Annemarie Wolf-Stiftung. Its product portfolio spans nine medical disciplines — urology, general surgery, gynecology, orthopedics, pneumology and thoracic surgery, spine surgery, proctology, pediatrics, and shockwave therapy — anchored by proprietary platforms including System blue (blue light photodynamic diagnosis cystoscopy for bladder cancer), System green (general surgery visualization), and core nova (operating room integration system connecting to hospital IT networks with data security guarantees). A 2026 strategic co-development partnership with Photocure ASA is producing a flexible PDD cystoscope and 4K global Flex system targeted for global launch in 2027.

The company operates a global hybrid distribution model combining 18 wholly-owned subsidiaries across Germany, Austria, Belgium, the UK, USA, Japan, Brazil, and China with a network of approximately 130 international distributors, employing over 1,700 people. Revenue is generated primarily through enterprise hardware sales of endoscopic instruments and integrated systems, supplemented by professional service streams (repairs, spare parts, loan equipment, on-site service, hotline support, and pickup service) and customized multi-year financing concepts that help hospitals manage capital investment cycles. The go-to-market is enterprise field sales-led, supported by active participation in international medical congresses, an in-house Academy Prima Vista training program with locations in Knittlingen, Vernon Hills, Beijing, and Dubai, and a multi-language digital presence spanning website, social media, and the eMagazine "the spirit". Customer segments explicitly addressed include commercial decision-makers, surgeons and physicians, OR functional staff, medical technicians, hospital IT personnel, and AEMP/sterile supply departments, with a diversification into aerospace turbine maintenance, repair, and overhaul applications via Blending Scopes technology.

Short descriptiontext

Richard Wolf GmbH is a German medical technology company that develops and sells endoscopic instruments and integrated system solutions for minimally invasive surgery across nine medical specialties, serving hospitals and surgical centers worldwide through 18 subsidiaries and 130 distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersDubai, United Arab Emirates
HQ citystring
Dubai
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical endoscopy devices, minimally invasive surgery, endoscopic imaging systems, surgical instruments, medical technology
Industry8 codes
PRIMARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAN
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAOAF
Endourology & Minimally Invasive Urologic Surgery
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)
SECONDARYHLAKALAC
Orthopedic Surgery (Operative Orthopedics)
SECONDARYHLACAGAJ
Surgical, Perioperative & ERAS Pathway Tools
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Endoscopy Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical endoscopy instruments and systems
TypeHardware Sales
Description

Sale of endoscopic instruments and complete system solutions for minimally invasive procedures across multiple medical disciplines. Products are developed in close cooperation with scientists and physicians, are perfectly coordinated and suitable for multiple specialties.

richard-wolf.com
2Service and repair
TypeProfessional Services
Description

Technical service including repairs, spare parts, exchange and loan equipment, on-site service, hotline support, and pickup service for maintenance of medical equipment

richard-wolf.com
3Financing concepts
TypeLicensing Royalties
Description

Individual financing concepts offered to customers to remain flexible and avoid investment bottlenecks

richard-wolf.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom enterprise pricing with financing options
ModelOtherBilling cadenceMulti-year contract
Notes

Richard Wolf offers individual financing concepts rather than standard pricing tiers. Direct consultation and customized quotes provided based on customer requirements.

richard-wolf.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Richard Wolf develops, manufactures, and sells endoscopic instruments and complete system solutions for minimally invasive surgery across nine medical disciplines including urology, surgery, gynecology, orthopedics, pneumology/thoracic surgery, spine surgery, proctology, pediatrics, and shockwave therapy. The portfolio includes proprietary imaging platforms (System green for general surgery, System blue for blue-light cystoscopy), the core nova OR integration system for hospital IT connectivity, and a broad range of specialized endoscopic instruments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Instruments designed for multiple disciplines enabling cross-disciplinary use
+1 more record
Product overview1 text field

Richard Wolf is a complete provider (Komplettanbieter) for endoscopy, offering a comprehensive portfolio of innovative instruments and system solutions for minimally invasive procedures. The product architecture consists of core imaging systems (System green for surgery, System blue for urology/blue light cystoscopy), the core nova OR integration platform enabling hospital IT connectivity, specialized instruments for nine medical disciplines (urology, surgery, gynecology, orthopedics, pneumology/thorax surgery, spine surgery, proktologie, pediatrics, shockwaves), and supporting services including Academy Prima Vista training and instrument hygiene solutions. A notable partnership with Photocure focuses on flexible PDD-cystoscope development for bladder cancer diagnostics.

Product and service5 records
1System green
CategoryEndoscopic Imaging Systems
Description

Endoscopic imaging system designed for general surgery applications, enabling visualization during minimally invasive procedures.

2System blue
CategoryEndoscopic Imaging Systems
Description

Blue light cystoscopy system for urology enabling enhanced visualization and early detection of bladder cancer through photodynamic diagnosis (PDD). Developed in partnership with Photocure.

3core nova
CategoryOR Integration Systems
Description

Operating room integration system enabling seamless connection to existing hospital IT networks, facilitating data management, workflow integration, and data security in surgical environments.

4Shockwave Therapy Systems
CategoryTherapy Systems
Description

Extracorporeal shock wave therapy systems for treatment of musculoskeletal conditions, stone disintegration, wound healing, and erectile dysfunction.

5Flexible PDD-Cystoscope
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Richard Wolf and Photocure are co-developing a new flexible PDD (photodynamic diagnosis) cystoscope for bladder cancer detection. The partnership includes development of a 4K global Flex system targeted for global launch in 2027. Richard Wolf provides the flexible cystoscopy platform while Photocure contributes its Hexvix/Cysview photodynamic diagnostic technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

German privately held medtech incumbent with Aesculap surgical instruments and a growing endoscopy presence; comparable in ownership profile and German manufacturing heritage, overlapping in general and gynecologic surgery.

TypeEmerging player
Description

US-listed women's-health-focused medtech with a gynecologic surgery franchise (MyoSure, NovaSure) — overlaps meaningfully with Richard Wolf's gynecology discipline and is increasingly competing in hysteroscopy and laparoscopy.

3Cook Medical
TypeDirect peer
Description

Privately held US medical device maker with strong urology, endoscopy and minimally invasive surgery product lines; competes with Richard Wolf especially in urological and gynecologic endoscopy consumables.

TypeBroad incumbent
Description

Global leader in flexible endoscopy and surgical imaging; competes with Richard Wolf across urology, general surgery and gynecology but offers a much broader portfolio (including consumer optics) and far larger scale.

TypeBroad incumbent
Description

Global surgical devices player with an endoscopy and sports-medicine franchise; overlaps with Richard Wolf in orthopedic endoscopy and sports-medicine minimally invasive procedures.

TypeBroad incumbent
Description

Major diversified medtech incumbent whose endoscopy, urology and surgical visualization divisions increasingly overlap with Richard Wolf's portfolio — particularly relevant as Stryker has entered European blue light cystoscopy.

TypeDirect peer
Description

The closest direct competitor to Richard Wolf: a German privately held family/foundation-owned endoscopy specialist with a similar global multi-specialty endoscopy portfolio and comparable Komplettanbieter positioning across human medicine.

TypeEmerging player
Description

Growing medtech division of FUJIFILM with flexible endoscopy systems and surgical imaging solutions; competes with Richard Wolf in endoscopy imaging across urology and general surgery, particularly in APAC.

TypeDirect peer
Description

US-listed surgical and endoscopy device maker with a comparable portfolio in general surgery, gynecologic laparoscopy and urology — a focused mid-cap peer most analogous to Richard Wolf's multi-specialty endoscopy strategy.

TypeBroad incumbent
Description

Large-cap medtech with a meaningful urology and endoscopy franchise (including LithoVue and single-use scopes) that competes with Richard Wolf in urology and select minimally invasive surgical segments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Richard Wolf

Medical Endoscopy Equipmentrichard-wolf.com

Richard Wolf GmbH is a German medical technology company that develops and sells endoscopic instruments and integrated system solutions for minimally invasive surgery across nine medical specialties, serving hospitals and surgical centers worldwide through 18 subsidiaries and 130 distributors.

What Richard Wolf does

Richard Wolf GmbH is a privately held German medical technology company headquartered in Knittlingen, Germany, specializing in endoscopic instruments and complete system solutions for minimally invasive surgery. Founded in 1906 as a family business and formally incorporated as Richard Wolf GmbH in 1947, the company has been wholly owned since 1969 by the non-profit Richard und Annemarie Wolf-Stiftung. Its product portfolio spans nine medical disciplines — urology, general surgery, gynecology, orthopedics, pneumology and thoracic surgery, spine surgery, proctology, pediatrics, and shockwave therapy — anchored by proprietary platforms including System blue (blue light photodynamic diagnosis cystoscopy for bladder cancer), System green (general surgery visualization), and core nova (operating room integration system connecting to hospital IT networks with data security guarantees). A 2026 strategic co-development partnership with Photocure ASA is producing a flexible PDD cystoscope and 4K global Flex system targeted for global launch in 2027.

The company operates a global hybrid distribution model combining 18 wholly-owned subsidiaries across Germany, Austria, Belgium, the UK, USA, Japan, Brazil, and China with a network of approximately 130 international distributors, employing over 1,700 people. Revenue is generated primarily through enterprise hardware sales of endoscopic instruments and integrated systems, supplemented by professional service streams (repairs, spare parts, loan equipment, on-site service, hotline support, and pickup service) and customized multi-year financing concepts that help hospitals manage capital investment cycles. The go-to-market is enterprise field sales-led, supported by active participation in international medical congresses, an in-house Academy Prima Vista training program with locations in Knittlingen, Vernon Hills, Beijing, and Dubai, and a multi-language digital presence spanning website, social media, and the eMagazine "the spirit". Customer segments explicitly addressed include commercial decision-makers, surgeons and physicians, OR functional staff, medical technicians, hospital IT personnel, and AEMP/sterile supply departments, with a diversification into aerospace turbine maintenance, repair, and overhaul applications via Blending Scopes technology.

Richard Wolf firmographics

Firmographics
Name
Richard Wolf
Legal name
Richard Wolf GmbH
Website
https://richard-wolf.com
Company type
Private
Founded year
1906
Operating status
Operating
Headcount range
251–500 employees
Short description
Richard Wolf GmbH is a German medical technology company that develops and sells endoscopic instruments and integrated system solutions for minimally invasive surgery across nine medical specialties, serving hospitals and surgical centers worldwide through 18 subsidiaries and 130 distributors.
Ownership category
akta.pro rank

Richard Wolf industry classification

Industry
Product category
Medical Endoscopy Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAN
Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAC
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAOAF
Endourology & Minimally Invasive Urologic Surgery
SECONDARYHLAKAJAF
Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)
SECONDARYHLAKALAC
Orthopedic Surgery (Operative Orthopedics)
SECONDARYHLACAGAJ
Surgical, Perioperative & ERAS Pathway Tools
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

Keywords

  • Medical endoscopy devices
  • Minimally invasive surgery
  • Endoscopic imaging systems
  • Surgical instruments
  • Medical technology

Where Richard Wolf is headquartered

Location

Headquarters

HQ city
Dubai
HQ country
United Arab Emirates
HQ region
Middle East

Offices9 records

Markets served

Richard Wolf business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical endoscopy instruments and systems: Sale of endoscopic instruments and complete system solutions for minimally invasive procedures across multiple medical disciplines. Products are developed in close cooperation with scientists and physicians, are perfectly coordinated and suitable for multiple specialties.
  2. Service and repair: Technical service including repairs, spare parts, exchange and loan equipment, on-site service, hotline support, and pickup service for maintenance of medical equipment
  3. Financing concepts: Individual financing concepts offered to customers to remain flexible and avoid investment bottlenecks

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing with financing options

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Richard Wolf product offering

Product offering

Core offering

Richard Wolf develops, manufactures, and sells endoscopic instruments and complete system solutions for minimally invasive surgery across nine medical disciplines including urology, surgery, gynecology, orthopedics, pneumology/thoracic surgery, spine surgery, proctology, pediatrics, and shockwave therapy. The portfolio includes proprietary imaging platforms (System green for general surgery, System blue for blue-light cystoscopy), the core nova OR integration system for hospital IT connectivity, and a broad range of specialized endoscopic instruments.

Product overview

Richard Wolf is a complete provider (Komplettanbieter) for endoscopy, offering a comprehensive portfolio of innovative instruments and system solutions for minimally invasive procedures. The product architecture consists of core imaging systems (System green for surgery, System blue for urology/blue light cystoscopy), the core nova OR integration platform enabling hospital IT connectivity, specialized instruments for nine medical disciplines (urology, surgery, gynecology, orthopedics, pneumology/thorax surgery, spine surgery, proktologie, pediatrics, shockwaves), and supporting services including Academy Prima Vista training and instrument hygiene solutions. A notable partnership with Photocure focuses on flexible PDD-cystoscope development for bladder cancer diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

  • System green Endoscopic imaging system designed for general surgery applications, enabling visualization during minimally invasive procedures.
  • System blue Blue light cystoscopy system for urology enabling enhanced visualization and early detection of bladder cancer through photodynamic diagnosis (PDD). Developed in partnership with Photocure.
  • core nova Operating room integration system enabling seamless connection to existing hospital IT networks, facilitating data management, workflow integration, and data security in surgical environments.
  • Shockwave Therapy Systems Extracorporeal shock wave therapy systems for treatment of musculoskeletal conditions, stone disintegration, wound healing, and erectile dysfunction.
  • Flexible PDD-Cystoscope

Quantifiable outcome

  • Instruments designed for multiple disciplines enabling cross-disciplinary use
  • +1 more outcomes

Companies that use Richard Wolf

Customer profile

Named customers1 record

Segments6 records

Ideal customer profiles3 records

Richard Wolf technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Richard Wolf partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Photocure ASAcoreStrategic or Co-development PartnerRichard Wolf and Photocure are co-developing a new flexible PDD (photodynamic diagnosis) cystoscope for bladder cancer detection. The partnership includes development of a 4K global Flex system targeted for global launch in 2027. Richard Wolf provides the flexible cystoscopy platform while Photocure contributes its Hexvix/Cysview photodynamic diagnostic technology.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Richard Wolf competitors and assessment

Company assessment

Broad incumbents

  • B. Braun SE: German privately held medtech incumbent with Aesculap surgical instruments and a growing endoscopy presence; comparable in ownership profile and German manufacturing heritage, overlapping in general and gynecologic surgery.
  • Olympus Corporation: Global leader in flexible endoscopy and surgical imaging; competes with Richard Wolf across urology, general surgery and gynecology but offers a much broader portfolio (including consumer optics) and far larger scale.
  • Smith & Nephew plc: Global surgical devices player with an endoscopy and sports-medicine franchise; overlaps with Richard Wolf in orthopedic endoscopy and sports-medicine minimally invasive procedures.
  • Stryker Corporation: Major diversified medtech incumbent whose endoscopy, urology and surgical visualization divisions increasingly overlap with Richard Wolf's portfolio — particularly relevant as Stryker has entered European blue light cystoscopy.
  • Boston Scientific Corporation: Large-cap medtech with a meaningful urology and endoscopy franchise (including LithoVue and single-use scopes) that competes with Richard Wolf in urology and select minimally invasive surgical segments.

Emerging players

  • Hologic, Inc. US-listed women's-health-focused medtech with a gynecologic surgery franchise (MyoSure, NovaSure) — overlaps meaningfully with Richard Wolf's gynecology discipline and is increasingly competing in hysteroscopy and laparoscopy.
  • FUJIFILM Healthcare: Growing medtech division of FUJIFILM with flexible endoscopy systems and surgical imaging solutions; competes with Richard Wolf in endoscopy imaging across urology and general surgery, particularly in APAC.

Direct peers

  • Cook Medical: Privately held US medical device maker with strong urology, endoscopy and minimally invasive surgery product lines; competes with Richard Wolf especially in urological and gynecologic endoscopy consumables.
  • Karl Storz SE & Co. KG: The closest direct competitor to Richard Wolf: a German privately held family/foundation-owned endoscopy specialist with a similar global multi-specialty endoscopy portfolio and comparable Komplettanbieter positioning across human medicine.
  • Conmed Corporation: US-listed surgical and endoscopy device maker with a comparable portfolio in general surgery, gynecologic laparoscopy and urology — a focused mid-cap peer most analogous to Richard Wolf's multi-specialty endoscopy strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Richard Wolf social profiles

Digital presence

Richard Wolf compliance and trust

Trust signal

Compliance1 record

Richard Wolf financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Richard Wolf leadership team

Management profile

Number of profiles

Profiles5 records

Richard Wolf subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Richard Wolf funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Richard Wolf M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Richard Wolf

What does Richard Wolf do?

Richard Wolf develops, manufactures, and sells endoscopic instruments and complete system solutions for minimally invasive surgery across nine medical disciplines including urology, surgery, gynecology, orthopedics, pneumology/thoracic surgery, spine surgery, proctology, pediatrics, and shockwave therapy. The portfolio includes proprietary imaging platforms (System green for general surgery, System blue for blue-light cystoscopy), the core nova OR integration system for hospital IT connectivity, and a broad range of specialized endoscopic instruments.

Is Richard Wolf a public or private company?

Richard Wolf is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Richard Wolf founded?

Richard Wolf was founded in 1906. It employs 251 to 500 people.

Where is Richard Wolf based?

Richard Wolf is headquartered in Dubai, United Arab Emirates, in the Middle East region.

How does Richard Wolf make money?

Three revenue lines are on record. Medical endoscopy instruments and systems are the primary driver. The others are service and repair and financing concepts.

Who are Richard Wolf's main competitors?

Broad incumbents on record are B. Braun SE, Olympus Corporation, Smith & Nephew plc, Stryker Corporation and Boston Scientific Corporation. Emerging players are Hologic, Inc. and FUJIFILM Healthcare. Direct peers are Cook Medical, Karl Storz SE & Co. KG and Conmed Corporation.

Does Richard Wolf have an API?

No public API is recorded for Richard Wolf.

What industry is Richard Wolf in?

Richard Wolf's product category is Medical Endoscopy Equipment. Its primary akta.pro industry code is HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireHysteroscopy Instruments Market Size to Exceed USD 3.45 Billion by 2032 with AI and Office-Based ShiftThe hysteroscopy instruments market is projected to grow from USD 1.98 billion in 2025 to USD 3.45 billion by 2032, a CAGR of 7.2%. Office-based procedures are the fastest-growing application, and AI-integrated systems are expected to become standard care.openPR.comEurope Cystoscopy Market See Incredible Growth 2026-2033 | Olympus Corporation, KARL STORZ SE & Co KG, Richard Wolf GmbH, Ambu A SCoherent Market Insights has published a market research report forecasting the growth of the Europe Cystoscopy Market from 2026 to 2033, detailing segmentation by type, application, and region. The study identifies key industry players including Olympus Corporation, KARL STORZ SE & Co KG, Richard Wolf GmbH, and Ambu A S as central participants in this evolving landscape.openPR.comU.S. Cystoscopy Market Future Business Opportunities 2026-2033 | Olympus Corporation, KARL STORZ, Richard Wolf Medical Instruments, StrykerCoherent Market Insights has published a market research report forecasting the U.S. Cystoscopy Market from 2026 to 2033, detailing segmentation by type, application, and end-user. The study analyzes key industry players including Olympus Corporation, KARL STORZ, Richard Wolf Medical Instruments, and Stryker, alongside other major competitors like Boston Scientific and Ambu. It provides strategic insights on investment hotspots, supply-demand dynamics, and competitive landscape trends for decision-makers.openPR.comGlobal Surgical Light Source Devices Market Size, Growth, Trends & Forecast to 2033 Linvatec Corporation, Getinge AB, Richard Wolf GmbHThe global market for surgical light source devices is expanding, with key companies like Linvatec Corporation, Getinge AB, and Richard Wolf GmbH participating in ongoing market research and development activities.The Manila TimesAndromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical DevelopmentAndromeda Surgical announced strategic partnerships with Richard Wolf and Quanta System to accelerate its robotic surgery platform. The system, designed for continuous software evolution, will initially focus on HoLEP, with 15 procedures completed in Chile and New Zealand. Expansion into other surgical specialties is planned.GlobeNewswireAndromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical DevelopmentAndromeda Surgical announced strategic partnerships with Richard Wolf and Quanta System to accelerate its robotic-assisted surgery platform. The system's first clinical application is HoLEP, with 15 procedures completed in Chile and New Zealand. The company plans to expand into multiple surgical specialties.YahooAndromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical DevelopmentAndromeda Surgical announced strategic partnerships with Richard Wolf and Quanta System to accelerate its robotic surgery platform. The system's first clinical application is HoLEP, with 15 procedures completed in Chile and New Zealand. The company plans to expand into other surgical specialties.Business InsiderAndromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical DevelopmentAndromeda Surgical announced strategic partnerships with Richard Wolf and Quanta System to accelerate its robotic-assisted surgery platform. The system's first clinical application is HoLEP, with 15 procedures completed in Chile and New Zealand. The company plans to expand into multiple surgical specialties.YahooAndromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical DevelopmentAndromeda Surgical announced partnerships with Richard Wolf and Quanta System to accelerate its robotic surgery platform, initially targeting HoLEP. The company has completed 15 procedures in its ASTRA study in Chile and New Zealand. The system's software is designed for continuous improvement, with plans to expand into other surgical specialties.